InsidersTradesSigma
Follow the 아미코젠 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 아미코젠 has logged 4 public disclosures. Market capitalisation: €81.7bn. The latest transaction was reported on 4 May 2026 (Purchase). Among the most active insiders: 아미코젠. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Amicogen 是一家在健康和制药领域运营的公司，在 XKRX 市场上市。该公司专注于生物制药产品和创新健康解决方案的开发。